Bioanalytical Testing Services

With expertise in custom synthesis, analytical services, and drug development.
We are here to support all your research needs by reducing the project timeline and cost.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Our Partners:

ARSI Canada
LC-MS/MS Method Development

For the quantification of drugs and metabolites in biological matrices.

ARSI Canada
ELISA Development and Validation

For the detection and quantification of proteins, antibodies, and biomarkers.

ARSI Canada
Chromatographic Method Development

Utilizing HPLC and UPLC for the analysis of small and large molecules.

Contract research organization

Why ARSI Canada Inc.?

Choosing ARSI Canada Inc. for your bioanalytical testing needs means partnering with a team dedicated to delivering excellence. Our rigorous testing processes, regulatory expertise, and commitment to quality ensure that your bioanalytical data is reliable and compliant, supporting the successful development and commercialization of your products.

Get in touch with ARSI Canada Inc. for comprehensive bioanalytical testing services and ensure your analytical methods are robust, reliable, and ready for regulatory approval.

FAQs about Bioanalytical Testing at ARSI Canada Inc.

What is bioanalytical testing?

Bioanalytical testing involves the analysis of biological samples (such as blood, plasma, urine, and tissues) to quantify drugs, metabolites, and biomarkers. It is crucial for understanding the pharmacokinetics, pharmacodynamics, and safety of drug candidates.

Why is bioanalytical testing important in drug development?

Bioanalytical testing is essential in drug development as it provides critical data on drug concentrations, metabolism, and therapeutic effects. This information supports regulatory submissions, ensures safety and efficacy, and aids in the development of personalized medicine.

What types of bioanalytical testing services does ARSI Canada Inc. offer?

ARSI Canada Inc. offers a wide range of bioanalytical testing services, including method development and validation, pharmacokinetic and pharmacodynamic studies, biomarker analysis, and immunogenicity testing. Our services are tailored to meet the specific needs of each project.

How does ARSI ensure the accuracy and reliability of bioanalytical testing?

ARSI ensures the accuracy and reliability of bioanalytical testing through rigorous method development and validation processes. We follow industry standards and regulatory guidelines to ensure that our methods produce consistent, accurate, and reproducible results.

What technologies does ARSI use for bioanalytical testing?

ARSI uses advanced technologies and instrumentation for bioanalytical testing, including LC-MS/MS, HPLC, UPLC, ELISA, and various immunoassay techniques. These technologies enable precise and accurate analysis of biological samples.

Can ARSI develop bioanalytical methods for complex biological matrices?

Yes, ARSI has extensive experience in developing bioanalytical methods for complex biological matrices such as blood, plasma, urine, and tissues. We tailor our methods to address the specific challenges associated with different sample types.

How long does bioanalytical method development and validation take?

The duration of bioanalytical method development and validation depends on the complexity of the method and specific project requirements. Typically, it can take several weeks to a few months. ARSI works closely with clients to provide accurate timelines and ensure timely delivery of results.

What industries benefit from ARSI's bioanalytical testing services?

ARSI's bioanalytical testing services benefit a wide range of industries, including pharmaceuticals, biotechnology, clinical research, environmental testing, and personalized medicine. Our expertise ensures reliable and compliant analytical methods across various sectors.

How does ARSI ensure regulatory compliance in bioanalytical testing?

ARSI ensures regulatory compliance in bioanalytical testing by adhering to guidelines set by the International Council for Harmonisation (ICH), the United States Pharmacopeia (USP), and other relevant regulatory bodies. Our testing processes meet global regulatory standards.

What documentation is provided after bioanalytical testing?

After bioanalytical testing, ARSI provides comprehensive documentation, including validation reports, standard operating procedures (SOPs), and detailed method development records. This documentation supports regulatory submissions and quality assurance processes.

Discuss your drug discovery & development needs, get a custom quote today!